The Food and Drugs Authority in Ghana has not registered any cannabis-containing products for industrial or clinical use. Accordingly, the FDA must be notified of any sales to unregistered products.
This is in response to a Ghana News Agency article published January 5, 2020. The headline was “Medicinal marijuana, effective treatment for chronic pain-Biochemist”.
“The attention of the Food and Drugs Authority (FDA) has been drawn to a media post circulating within the public domain by a biochemist, Dr George Cobla, purported to be affiliated with the FDA.
“The FDA would like to bring to the attention of the public that, Dr George Cobla is neither a staff of the institution nor has he been authorized to represent the FDA in this regard”.
It said “The use of cannabis for medical and industrial purposes is legal in Ghana in accordance with the Public Health Act, 2012 (Act 851) and the Narcotics Control Commission (NCC) Act, 2020 (Act Health Act 2012 (Act 851).”
Dr. Cobla also clarified that he refused to give an interview to any GNA reporter.
GNA
